Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients

American Journal of Transplantation

Volumn 2, Issue 10, 2002, Pages 965-969

  Choy, Bo Ying ^a   Peiris, J S Malik ^a   Chan, Tak Mao ^a   Lo, Simon K F ^a   Lui, Sing Leung ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatitis B vaccine; Immunogenicity; Intradermal; Transplant

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; PREDNISOLONE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; VACCINATION;

ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRADERMAL; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; TIME FACTORS;

EID: 0344837776     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.21014.x     Document Type: Article

References (20)

1. Rao KV, Kasiske BL, Anderson WR. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Transplantation 1991; 51: 391-396.
2. Kang SW, Lee SW, Choi KH et al. Clinical outcome of HbsAg (+) renal allograft recipients. Transplant Proc 1996; 28: 1653-1654.
3. Degos F, Degott C. Hepatitis in renal transplant recipients. J Hepatol 1989; 9: 114-123.
4. Feuerhake A, Muller R, Lauchart W. Pichlmayr R, Schmidt FW. HBV-vaccination in recipients of kidney allografts. Vaccine 1984; 2: 255-256.
5. Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine 1993; 11: 397-399.
6. Henderson EA, Louie TJ, Ramotar K, Ledgerwood D, Hope KM, Kennedy A. Comparison of higher dose intradermal hepatitis B vaccination of healthcare workers. Infect Control Hosp Epidemiol 2000; 21: 264-269.
7. Kurugol Z, Erensoy S, Aksit S, Egemen A, Bilgic A. Low dose intradermal administration of recombinant hepatitis B vaccine in children: 5-years follow up study. Vaccine 2001; 19: 3936-3939.
8. Levitz RE, Cooper BW, Regan HC. Immunization with high dose intradermal recombinant hepatitis B vaccine in health care workers who failed to respond to intramuscular vaccination. Infect Control Hosp Epidemiol 1995; 16: 88-91.
9. Waite NM, Thomson LG, Goldstein MB. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously non-responsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 1995; 5: 1930-1934.
10. Vlassopoulos D, Arvanitis D, Lilis D, Hatjiyannakos D, Louizou K, Hadjiconstantinou V. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients. Ren Fail 1997; 19: 455-460.
11. Struve J, Aronsson B, Frenning B, Granath F, Von-Sydow M, Weiland O. Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response. Scand J Infect Dis 1992; 24: 423-429.
12. Alper CA, Kruskall MS, Marcus-Bagley D et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989: 321: 708-712.
13. Caillat-Zucman S, Gimenez JJ, Wambergue F et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int 1998; 53: 1626-1630.
14. Hatae K, Kimura A, Okubo R et al. Genetic control of nonresponsiveness to hepatitis B vaccine by an extended HLA haplotype. Eur J Immunol 1992; 22: 1899-1905.
15. Volti SL, Caruso-Nicoleti M, Biazzo F et al. Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insutin dependent diabetes mellitus. Arch Dis Child 1998; 78: 54-57.
16. Prospt T, Propst A, Lhotta K, Vogel W, Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patient is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 1998; 32: 1041-1045.
17. Braathen L, Thorsby E. Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol 1980; 11: 401-408.
18. Zuckerman AJ. Appraisal of intradermal immunization against hepatitis B. Lancet 1987; i: 435-436.
19. Gerlich WH, Bruss V. Functions of hepatitis B virus proteins and molecular targets for protective immunity. In: Ellis RW ed. Hepatitis B Vaccines in Clinical Practice. New York, USA: Marcel Dekker, Inc. 1993. pp. 41-82.
20. Winström J. Intramuscular vs interdermal hepatitis B vaccination: a 6 year follow-up. JAMA 1995; 273: 1835-1836.